Theresa Payne
Nurse Practitioner · Rancho Mirage, CANPI 1083705909
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Amgen at 52.0% of the total. Reporting peaked in 2021 at $20,419 and has fallen 96.9% since, to $637 in 2025. Among nurse practitioner clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 175 payments — averaging $140.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$13K
- AstraZeneca$9K
- Vifor Pharma, Inc.$510
- Akebia Therapeutics Inc$423
- Calliditas Therapeutics US Inc.$409
- GSK$291
- plus $1K from 12 others
What the payments were for
- Consulting fees$1,5006%
- Speaking & faculty fees$14,35059%
- Travel & lodging$3,24613%
- Food & beverage$5,42922%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 48 | $12,762 |
| AstraZeneca | 51 | $9,047 |
| Vifor Pharma, Inc. | 11 | $510 |
| Akebia Therapeutics Inc | 9 | $423 |
| Calliditas Therapeutics US Inc. | 11 | $409 |
| GSK | 8 | $291 |
| Otsuka America Pharmaceutical, Inc. | 8 | $268 |
| Ardelyx, Inc. | 3 | $154 |
| Mallinckrodt Hospital Products Inc. | 6 | $126 |
| Baxter Healthcare | 1 | $125 |
| Bayer | 6 | $119 |
| Aurinia Pharma U.S., Inc. | 5 | $102 |
| Apellis Pharmaceuticals, Inc. | 2 | $45 |
| Nxstage Medical, Inc. | 1 | $44 |
| Fresenius USA Marketing, Inc. | 2 | $37 |
| Travere Therapeutics, Inc. | 1 | $25 |
| OPKO Pharmaceuticals, LLC | 1 | $25 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Parsabiv$11,738
- LOKELMA$7,725
- Veltassa$233
- Renal - PD$125
- FARXIGA$125
- XPHOZAH 30 MG$125
- TARPEYO$123
- JYNARQUE$121
- BENLYSTA$115
- AURYXIA$109
How this compares
$24,526 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XphozahTenapanor Hcl | 19 | $52,285 |
| Hydralazine Hcl | 13 | $152 |
| Amlodipine Besylate | 11 | $64 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Rancho Mirage
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$884K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.